Literature DB >> 16407684

Characteristics and management of patients presenting to the emergency department with hypertensive urgency.

Seth R Bender1, Michael W Fong, Sabine Heitz, John D Bisognano.   

Abstract

Few studies have examined the characteristics of patients presenting with hypertensive urgency, factors contributing to their presentation, or their management. The time and cost associated with treatment are unknown. Retrospective analysis of 50 emergency department patients with hypertensive urgency (symptomatic blood pressure (BP) elevation focusing on systolic BP >180 mm Hg or diastolic BP >110 mm Hg) was performed. The hospital database was queried to determine the cost of the average treat-and-release visit. The mean age was 54.3+/-15.6 years; 64% were female; 46% were black; 90% had diagnosed hypertension. The mean presenting BP was 198+/-27.6/109+/-17.3 mm Hg; 66% had systolic BP >180 mm Hg, and 38% had diastolic BP >110 mm Hg. Initially, 30% were not on antihypertensives, and 28% were on monotherapy. Headache (42%) and dizziness (30%) were most frequently reported symptoms. Presentation was most often attributed to running out of medication (16%). IV and oral labetalol were given to 28% and 24% of patients, respectively. Fifty-six percent of patients had no change in baseline therapy at discharge. The average emergency department stay was 5 hours 17 minutes +/- 4 hours 27 minutes. The average cost for similar visits in 2004 was 1543 dollars per visit. Emergency department visits for hypertensive urgency are related mostly to noncompliance. Labetalol was the most frequently used therapy. Management in the primary care office could result in substantial cost savings.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16407684      PMCID: PMC8109533          DOI: 10.1111/j.1524-6175.2005.04898.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  28 in total

Review 1.  Treatment of hypertensive crisis.

Authors:  D A Calhoun; S Oparil
Journal:  N Engl J Med       Date:  1990-10-25       Impact factor: 91.245

2.  Treatment of hypertensive urgencies with oral nifedipine, nicardipine, and captopril.

Authors:  B Komsuoğlu; B Sengün; A Bayram; S S Komsuoğlu
Journal:  Angiology       Date:  1991-06       Impact factor: 3.619

3.  Hypertensive crisis profile. Prevalence and clinical presentation.

Authors:  José Fernando Vilela Martin; Erika Higashiama; Evandro Garcia; Murilo Rizzatti Luizon; José Paulo Cipullo
Journal:  Arq Bras Cardiol       Date:  2004-08-17       Impact factor: 2.000

4.  Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

Authors:  Ihab Hajjar; Theodore A Kotchen
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

5.  Duration of antihypertensive effect of a single daily dose of hydrochlorothiazide.

Authors:  A Lutterodt; S Nattel; P J McLeod
Journal:  Clin Pharmacol Ther       Date:  1980-03       Impact factor: 6.875

6.  Clinical evaluation of intravenous labetalol for the treatment of hypertensive urgency.

Authors:  J Huey; J P Thomas; D R Hendricks; A E Wehmeyer; L J Johns; P E MacCosbe
Journal:  Am J Hypertens       Date:  1988-07       Impact factor: 2.689

7.  Hypertensive urgencies and emergencies. Prevalence and clinical presentation.

Authors:  B Zampaglione; C Pascale; M Marchisio; P Cavallo-Perin
Journal:  Hypertension       Date:  1996-01       Impact factor: 10.190

8.  Intravenous nicardipine for the treatment of severe hypertension. A double-blind, placebo-controlled multicenter trial.

Authors:  J D Wallin; E Fletcher; C V Ram; M E Cook; D G Cheung; E P MacCarthy; R Townsend; E Saunders; W R Davis; H G Langford
Journal:  Arch Intern Med       Date:  1989-12

9.  Intravenous urapidil versus sublingual nifedipine in the treatment of hypertensive urgencies.

Authors:  M M Hirschl; D Seidler; A Zeiner; A Wagner; G Heinz; F Sterz; A N Laggner
Journal:  Am J Emerg Med       Date:  1993-11       Impact factor: 2.469

10.  Intravenous fenoldopam versus sodium nitroprusside in patients with severe hypertension.

Authors:  E Reisin; M M Huth; B P Nguyen; S G Weed; F M Gonzalez
Journal:  Hypertension       Date:  1990-02       Impact factor: 10.190

View more
  11 in total

Review 1.  Asymptomatic Elevated BP and the Hypertensive Insurgency.

Authors:  Candace D McNaughton; Phillip Levy
Journal:  Curr Hypertens Rep       Date:  2016-12       Impact factor: 5.369

2.  Can Diastolic Blood Pressure Decrease in Emergency Department Setting be Anticipated?

Authors:  Irit Ayalon-Dangur; Tzippy Shochat; Shachaf Shiber; Alon Grossman
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-05-23

3.  Hypertensive Urgency Treatment and Outcomes in a Northeast Thai Population: The Results from the Hypertension Registry Program.

Authors:  Praew Kotruchin; Thapanawong Mitsungnern; Ratkamon Ruangsaisong; Supap Imoun; Chatlert Pongchaiyakul
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-07-26

4.  Clinical characteristics of Black patients with hypertensive urgency.

Authors:  Robert Munashe Maweni; Nicholas Sunderland; Zahra Rahim; Emmanuella Odih; Jins Kallampallil; Thomas Saunders; Srikanth Akunuri
Journal:  Ir J Med Sci       Date:  2018-03-14       Impact factor: 1.568

Review 5.  Severe hypertension in children and adolescents: pathophysiology and treatment.

Authors:  Joseph T Flynn; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2008-10-07       Impact factor: 3.714

6.  Hypertensive Crisis, Burden, Management, and Outcome at a Tertiary Care Center in Karachi.

Authors:  Aysha Almas; Ayaz Ghouse; Ahmed Raza Iftikhar; Munawwar Khursheed
Journal:  Int J Chronic Dis       Date:  2014-08-18

7.  10-Year community prevalence and trends of severe asymptomatic hypertension among patients with hypertension in the USA: 2007-2016.

Authors:  Muchi Ditah Chobufo; Ebad Ur Rahman; Fatima Farah; Mohamed Suliman; Kanaan Mansoor; Adee Elhamdani; Mehiar El-Hamdani; Sudarshan Balla
Journal:  Int J Cardiol Hypertens       Date:  2020-11-03

8.  Evaluation of the clinical outcome of captopril use for hypertensive urgency in Khartoum State's emergency centres.

Authors:  Amgad H H Obied; Aimun A E Ahmed
Journal:  Afr J Emerg Med       Date:  2020-11-19

9.  Retinal and Choroidal Capillary Perfusion Are Reduced in Hypertensive Crisis Irrespective of Retinopathy.

Authors:  Jan Henrik Terheyden; Maximilian W M Wintergerst; Carmen Pizarro; Maximilian Pfau; Gabrielle N Turski; Frank G Holz; Robert P Finger
Journal:  Transl Vis Sci Technol       Date:  2020-07-29       Impact factor: 3.283

10.  Clinical treatment outcomes of hypertensive emergency patients: Results from the hypertension registry program in Northeastern Thailand.

Authors:  Praew Kotruchin; Wachira Pratoomrat; Thapanawong Mitsungnern; Sittichai Khamsai; Supap Imoun
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-12-07       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.